(Circulation. 1997;96:1477-1481.)
© 1997 American Heart Association, Inc.
Articles |
,25-Dihydroxyvitamin D3 Are Independent Predictors of Coronary Calcium Mass Measured by Electron-Beam Computed Tomography
From the Division of Cardiology, Department of Medicine, HarborUCLA Medical Center, and the Saint John's Cardiovascular Research Center (T.M.D., W.T., S.D., R.C.D.), Torrance, Calif; Division of Cardiology (K.E.W., L.L.D.), Department of Medicine, UCLA School of Medicine, Los Angeles, Calif; and Department of Statistics (R.M.S.), University of California, Riverside.
Correspondence to Robert Detrano, MD, PhD, Division of Cardiology, HarborUCLA Medical Center, 1124 W Carson St, RB-2, Torrance, CA 90502. E-mail detrano{at}harbor4.humc.edu
Background Blacks have been found to have lower amounts of coronary calcium as well as higher levels of the osteoregulatory steroid 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] than whites. We sought to determine if racial differences in coronary calcium mass could be explained by differences in serum levels of 1,25(OH)2D3.
Methods and Results We evaluated standard coronary risk factors, quantified coronary calcium mass with electron-beam computed tomography (EBCT), and measured serum 1,25(OH)2D3 with radioimmunoassay in 283 high-risk subjects (51 [18%] black, 232 [82%] white). Black subjects had lower masses of coronary calcium than whites (14 versus 47 mg; P=.003). Serum 1,25(OH)2D3 levels were slightly higher in blacks (41 versus 38 pg/mL; P=.05). Log 1,25(OH)2D3 levels were inversely proportional to log-transformed calcium mass (r=-.19; P=.001) in both races. Multivariate linear regression demonstrated that both black race (P=.02) and 1,25(OH)2D3 levels (P=.007) contributed inversely and independently to coronary calcium mass. However, an interaction term of racex1,25(OH)2D3 did not significantly contribute to coronary calcium mass, indicating that other undetermined factors in addition to 1,25(OH)2D3 are responsible for ethnic differences in coronary calcium mass.
Conclusions Both black race and serum levels of 1,25(OH)2D3 are independent negative determinants of coronary calcium mass. Nevertheless, diminished amounts of coronary calcium in blacks are not accounted for by higher 1,25(OH)2D3 levels.
Key Words: calcium vitamin D race tomography
This article has been cited by other articles:
![]() |
O. Tarcin, D. G. Yavuz, B. Ozben, A. Telli, A. V. Ogunc, M. Yuksel, A. Toprak, D. Yazici, S. Sancak, O. Deyneli, et al. Effect of Vitamin D Deficiency and Replacement on Endothelial Function in Asymptomatic Subjects J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 4023 - 4030. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mizobuchi, D. Towler, and E. Slatopolsky Vascular Calcification: The Killer of Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1453 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Atkinson Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences J Appl Physiol, November 1, 2008; 105(5): 1643 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Hsu, Y. Tintut, and L. L. Demer Vitamin D and Osteogenic Differentiation in the Artery Wall Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1542 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mathew, R. J. Lund, L. R. Chaudhary, T. Geurs, and K. A. Hruska Vitamin D Receptor Activators Can Protect against Vascular Calcification J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1509 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mehrotra, D. Kermah, M. Budoff, I. B. Salusky, S. S. Mao, Y. L. Gao, J. Takasu, S. Adler, and K. Norris Hypovitaminosis D in Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1144 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Wang, M. J. Pencina, S. L. Booth, P. F. Jacques, E. Ingelsson, K. Lanier, E. J. Benjamin, R. B. D'Agostino, M. Wolf, and R. S. Vasan Vitamin D Deficiency and Risk of Cardiovascular Disease Circulation, January 29, 2008; 117(4): 503 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hravnak, J. Whittle, M. E. Kelley, S. Sereika, C. B. Good, S. A. Ibrahim, and J. Conigliaro Symptom Expression in Coronary Heart Disease and Revascularization Recommendations for Black and White Patients Am J Public Health, September 1, 2007; 97(9): 1701 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Johnson, J. A. Leopold, and J. Loscalzo Vascular Calcification: Pathobiological Mechanisms and Clinical Implications Circ. Res., November 10, 2006; 99(10): 1044 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Freedman, D. W. Bowden, M. M. Sale, C. D. Langefeld, and S. S. Rich Genetic Susceptibility Contributes to Renal and Cardiovascular Complications of Type 2 Diabetes Mellitus Hypertension, July 1, 2006; 48(1): 8 - 13. [Full Text] [PDF] |
||||
![]() |
M. Cigolini, M. P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, and G. Targher Serum 25-hydroxyvitamin d3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care, March 1, 2006; 29(3): 722 - 724. [Full Text] [PDF] |
||||
![]() |
D. E. Bild, R. Detrano, D. Peterson, A. Guerci, K. Liu, E. Shahar, P. Ouyang, S. Jackson, and M. F. Saad Ethnic Differences in Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA) Circulation, March 15, 2005; 111(10): 1313 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.E. Norman and J.T. Powell Vitamin D, Shedding Light on the Development of Disease in Peripheral Arteries Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 39 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification Endocr. Rev., August 1, 2004; 25(4): 629 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Lee, P. G. O'Malley, I. Feuerstein, and A. J. Taylor The prevalence and severity of coronaryartery calcification on coronary arterycomputed tomography in black and white subjects J. Am. Coll. Cardiol., January 1, 2003; 41(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Bild, A. R. Folsom, L. P. Lowe, S. Sidney, C. Kiefe, A. O. Westfall, Z.-J. Zheng, and J. Rumberger Prevalence and Correlates of Coronary Calcification in Black and White Young Adults : The Coronary Artery Risk Development in Young Adults (CARDIA) Study Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 852 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B. Salusky and W. G. Goodman Managing phosphate retention: is a change necessary? Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1738 - 1742. [Full Text] [PDF] |
||||
![]() |
T. M. Doherty, W. Tang, and R. C. Detrano Racial differences in the significance of coronary calcium in asymptomatic black and white subjects with coronary risk factors J. Am. Coll. Cardiol., September 1, 1999; 34(3): 787 - 794. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |